₨ Official source-observed price
PKR 30.99
30's
PKR 1.03 / tablet
✓ Official DRAP price source observed · Source checked 2026-09-23
Price Intelligence
Equivalent price position
Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →
This brandPKR 1.03/ tablet
Price position34% above medianvs like-for-like peer median
Peer comparators12current-price listings
🔒
MedInfoBase Pharma Pro
View Price Intelligence PRO
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Rank & percentilePeer medianFull competitor listPortfolio intelligence
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Diazepam
- Therapeutic area
- CNS & mental health
- Drug class
- Benzodiazepines / sedatives
- ATC
- N05BA
- Strength
- 2 mg
- Dosage form
- Tablet
- Pack
- 30's
- Registration no.
- 112693
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-09-23 03:18
Manufacturer
Bryon Pharmaceuticals (Pvt.) Ltd
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Traceability
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 30.99 | 2026-07-29 | 2026-08-09 | DRAP PharmaPrice Index | Current |
Same generic
Other listed brands
Arzepam 5 mgArsons Pharmaceutical Industries (Pvt) Ltd · PKR 59.34Arzepam 5 mgArsons Pharmaceutical Industries (Pvt) Ltd · PKR 1,340.25Bryzepam 5 mgBryon Pharmaceuticals (Pvt.) Ltd · PKR 61.96Bryzepam 10 mgBryon Pharmaceuticals (Pvt.) Ltd · PKR 103.27Daz 5 mgSAFE PHARMACEUTICAL (PVT) LTD · PKR 45.03Daz 10 mgSAFE PHARMACEUTICAL (PVT) LTD · PKR 75.05Daz 10 mg/2 mLSAFE PHARMACEUTICAL (PVT) LTD · PKR 3,314.13Daz 5 mgSAFE PHARMACEUTICAL (PVT) LTD · PKR 828.53
Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.
Cite this record
Medicine record · DRAP registration 112693MedInfoBase. (2026). Bryzepam 2 mg Tablet (30's), Bryon Pharmaceuticals (Pvt.) Ltd — registration and price record [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/brand/bryzepam-2-mg-112693-30s-bryon-pharmaceuticals-pvt-ltd/ Data observed 9 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 112693.
MedInfoBase. Bryzepam 2 mg Tablet (30's), Bryon Pharmaceuticals (Pvt.) Ltd — registration and price record [Internet]. Islamabad: MedInfoBase; 2026 [cited 2026 Sep 23]. Available from: https://medinfobase.com/brand/bryzepam-2-mg-112693-30s-bryon-pharmaceuticals-pvt-ltd/ Data observed 9 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 112693.
MedInfoBase (2026) Bryzepam 2 mg Tablet (30's), Bryon Pharmaceuticals (Pvt.) Ltd — registration and price record. Available at: https://medinfobase.com/brand/bryzepam-2-mg-112693-30s-bryon-pharmaceuticals-pvt-ltd/ (Accessed: 23 September 2026).
"Bryzepam 2 mg Tablet (30's), Bryon Pharmaceuticals (Pvt.) Ltd — registration and price record." MedInfoBase, 2026, https://medinfobase.com/brand/bryzepam-2-mg-112693-30s-bryon-pharmaceuticals-pvt-ltd/. Accessed 23 Sep 2026.
MedInfoBase. 2026. "Bryzepam 2 mg Tablet (30's), Bryon Pharmaceuticals (Pvt.) Ltd — registration and price record." Accessed September 23, 2026. https://medinfobase.com/brand/bryzepam-2-mg-112693-30s-bryon-pharmaceuticals-pvt-ltd/.
Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.
